Pharvaris N.V.
PHVS · NASDAQ · USD
$31.10
−0.02 −0.06%todayNot financial advice.
- Open
- 31.14
- Day range
- 31.09 - 31.96
- 52-week range
- 20.65 - 43.25
- Volume
- 754.99K
- Market cap
- 2.17B
- P/E ratio
- —
- EPS
- -3.05
- Dividend yield
- 0.00%
- Beta
- 0.61
Performance
W
−0.35%
1M
−18.71%
3M
−13.10%
6M
+14.72%
YTD
+11.23%
Y
+31.67%
5Y
+81.87%
All
+24.40%
In the news
Oct 8
Pharvaris Phase 3 Trial for Oral HAE Treatment Meets All Endpoints
Pharvaris announced its oral drug deucrictibant met all endpoints in a Phase 3 study for HAE attacks, with FDA approval decision set for April 2027.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-PHVS" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Pharvaris N.V. (PHVS) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-PHVS">PHVS stock price</a> by FreeTheAI Stocks</p>